Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Multi-level drug response"'
Autor:
Xinyan Zhang, Bingzong Li, Huiying Han, Sha Song, Hongxia Xu, Yating Hong, Nengjun Yi, Wenzhuo Zhuang
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background Multiple myeloma (MM), like other cancers, is caused by the accumulation of genetic abnormalities. Heterogeneity exists in the patients’ response to treatments, for example, bortezomib. This urges efforts to identify biomarkers
Externí odkaz:
https://doaj.org/article/db90006a66514a9ca196c92ff1094841
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sha Song, Yating Hong, Bingzong Li, Hongxia Xu, Nengjun Yi, Xinyan Zhang, Wenzhuo Zhuang, Huiying Han
Publikováno v:
BMC Cancer
BMC Cancer, Vol 18, Iss 1, Pp 1-9 (2018)
BMC Cancer, Vol 18, Iss 1, Pp 1-9 (2018)
Background Multiple myeloma (MM), like other cancers, is caused by the accumulation of genetic abnormalities. Heterogeneity exists in the patients’ response to treatments, for example, bortezomib. This urges efforts to identify biomarkers from nume
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc01f6fb6bb217b9fe541bbc960d940d
https://pubmed.ncbi.nlm.nih.gov/29747599
https://pubmed.ncbi.nlm.nih.gov/29747599
Autor:
Sha Song, Yating Hong, Hongxia Xu, Wenzhuo Zhuang, Xinyan Zhang, Huiying Han, Bingzong Li, Zixuan Yi, Nengjun Yi
Motivation Molecular analyses suggest that myeloma is composed of distinct sub-types that have different molecular pathologies and various response rates to certain treatments. Drug responses in multiple myeloma (MM) are usually recorded as a multi-l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::271ce94c59d7089972819f4c38266277
https://europepmc.org/articles/PMC6198861/
https://europepmc.org/articles/PMC6198861/
Autor:
Xinyan Zhang, Bingzong Li, Huiying Han, Song, Sha, Hongxia Xu, Yating Hong, Nengjun Yi, Wenzhuo Zhuang
Figure S1. Heatmap with Top 50 Significantly Probes with Drug response (Three Levels) in Mulligan et al. [10]. (DOCX 77Â kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb1e0078f020c688ab9ebab81c652c4b
Autor:
Xinyan Zhang, Bingzong Li, Huiying Han, Song, Sha, Hongxia Xu, Yating Hong, Nengjun Yi, Wenzhuo Zhuang
Figure S2. Heatmap with Top 50 Significantly Probes with Drug response (Three Levels) in Terragna et al. [2]. (DOCX 72Â kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cace27c277628d345b7da8b8914ee7c9
Autor:
Xinyan Zhang, Bingzong Li, Huiying Han, Song, Sha, Hongxia Xu, Yating Hong, Nengjun Yi, Wenzhuo Zhuang
Table S1. Summary of predictive performance using different number of top probes for drug response prediction (three levels) in two studies. (DOCX 21Â kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::257bba41305f715ed546baa1eddbc611
Publikováno v:
Briefings in Bioinformatics. Jan2023, Vol. 24 Issue 1, p1-12. 12p.
Publikováno v:
Statistical Methods in Medical Research; Jun2024, Vol. 33 Issue 6, p1043-1054, 12p